Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells

Adv Healthc Mater. 2015 Jan 7;4(1):65-8. doi: 10.1002/adhm.201400307. Epub 2014 Aug 7.

Abstract

Efficacious, potent, and at the same time nontoxic macromolecular prodrugs of ribavirin are designed taking advantage over prodrug activation by the intracellular milieu. Activity of these prodrugs is illustrated in the cells hosting hepatitis C virus replication and also in the cells implicated in the inflammatory response to the viral infection.

Keywords: drug delivery; hepatitis C virus; polymers; prodrugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents* / chemical synthesis
  • Antiviral Agents* / chemistry
  • Antiviral Agents* / pharmacology
  • Cell Line
  • Gene Expression Regulation, Viral / drug effects*
  • Genome, Viral*
  • Hepacivirus / genetics
  • Hepacivirus / metabolism*
  • Hepatitis C / drug therapy*
  • Hepatitis C / genetics
  • Hepatitis C / metabolism
  • Hepatitis C / pathology
  • Humans
  • Polymethacrylic Acids* / chemical synthesis
  • Polymethacrylic Acids* / chemistry
  • Polymethacrylic Acids* / pharmacology
  • Prodrugs* / chemical synthesis
  • Prodrugs* / chemistry
  • Prodrugs* / pharmacology
  • Ribavirin* / analogs & derivatives
  • Ribavirin* / chemical synthesis
  • Ribavirin* / chemistry
  • Ribavirin* / pharmacology

Substances

  • Antiviral Agents
  • Polymethacrylic Acids
  • Prodrugs
  • polymethacrylic acid
  • Ribavirin